Related references
Note: Only part of the references are listed.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Francois Quenet et al.
LANCET ONCOLOGY (2021)
Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A systematic review and discussion of latest controversies
Michael Flood et al.
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2020)
Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
Judith E. K. R. Hentzen et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
Leonardo Solaini et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study
Atuhani Burnett et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience
Vignesh Narasimhan et al.
DISEASES OF THE COLON & RECTUM (2019)
More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Daniel Solomon et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures
Jason M. Foster et al.
JAMA NETWORK OPEN (2019)
Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases
M. Tonello et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.
Francois Quenet et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial
Gabriel Glockzin et al.
CLINICAL COLORECTAL CANCER (2018)
Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
Can Yurttas et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Are there intra-operative hemodynamic differences between the Coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis? A retrospective cohort study
Cristina Rodriguez Silva et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC
Marcel Andre Schneider et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia
Nayef Alzahrani et al.
ANZ JOURNAL OF SURGERY (2016)
Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases A Meta-analysis
Riom Kwakman et al.
ANNALS OF SURGERY (2016)
Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Claramae Shulyn Chia et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience
Julie Navez et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis
En-Kwang Lin et al.
MEDICINE (2016)
Extent of Colorectal Peritoneal Carcinomatosis: Attempt to Define a Threshold Above Which HIPEC Does Not Offer Survival Benefit: A Comparative Study
Diane Goere et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: The experience of a tertiary Asian center
Melissa Ching Ching Teo et al.
ASIAN JOURNAL OF SURGERY (2015)
Evolution of Treatments for Peritoneal Metastases From Colorectal Cancer
Sarah O'Dwyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis
Geert A. Simkens et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis
Jesus Esquivel et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone
R. Mirnezami et al.
BRITISH JOURNAL OF CANCER (2014)
The American Society of Peritoneal Surface Malignancies Evaluation of HIPEC with Mitomycin C Versus Oxaliplatin in 539 Patients with Colon Cancer Undergoing a Complete Cytoreductive Surgery
Arancha Prada-Villaverde et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis from Rectal Cancer
Konstantinos I. Votanopoulos et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol
Anke M. J. Kuijpers et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Summary of current therapeutic options for peritoneal metastases from colorectal cancer
Terence C. Chua et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy
Yutaka Yonemura et al.
SCIENTIFIC WORLD JOURNAL (2013)
Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer
J. Segelman et al.
BRITISH JOURNAL OF SURGERY (2012)
Randomized Clinical Trials for Colorectal Cancer Peritoneal Surface Malignancy
Itzhak Avital et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Current Status and Future Directions in the Treatment of Peritoneal Dissemination from Colorectal Carcinoma
Dominique Elias et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
Terence C. Chua et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies
Pedro Bretcha-Boix et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin
Christopher Cao et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer with Peritoneal Surface Disease
Perry Shen et al.
CURRENT PROBLEMS IN CANCER (2009)
8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Vic J. Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center
Niraj J. Gusani et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis
Wim P. Ceelen et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies
P. Piso et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Failure analysis of recurrent disease following complete cytoreduction and Perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer
Lana Bijelic et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma
Tristan D. Yan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Peritoneal carcinomatosis of colorectal origin - Incidence and current treatment strategies
MJ Koppe et al.
ANNALS OF SURGERY (2006)
Treatment of peritoneal carcinomatosis from colorectal cancer: Impact of complete cytoreductive surgery and difficulties in conducting randomized trials
D Elias et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy
VJ Verwaal et al.
BRITISH JOURNAL OF SURGERY (2004)
Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin
J Glehen et al.
BRITISH JOURNAL OF SURGERY (2004)
Peritoneal carcinomatosis from colorectal cancer
DG Jayne et al.
BRITISH JOURNAL OF SURGERY (2002)
Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin
AJ Witkamp et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
